Financials
Financial year 2025
Gross margin
€ 4,288
▲ 350% vs 2024
Profit
Growing€ 3,725
▲ 2091% vs 2024
Debts
High€ 257,803
▲ 75% vs 2024
Amophar OTC from Schelle, company number BE0795483142, closed financial year 2025 with a result of € 3,725 after tax. For that financial year Amophar OTC recorded a gross margin of € 4,288 and equity of € 15,024. Compared with financial year 2024, the result moved from € 170 to € 3,725. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
What happened at Amophar OTC?
What happened at Amophar OTC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 3,725 (▲ 2091% vs 2024). Source: NBB ↗
- New establishment in Schelle. KBO
- LBS Besloten Vennootschap became a director. NBB
- INPHAGRO Besloten Vennootschap became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1,130 profit in 2023 to € 3,725 profit in 2025.
Paid € 1,675 in corporate taxes since 2023.
Best year ever: 2025, with € 3,725 profit.
A new publication or filing at Amophar OTC? We notify you, reason included.
Follow Amophar OTCNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Amophar OTC are LBS Besloten Vennootschap and INPHAGRO Besloten Vennootschap. The shares are held by INPHAGRO.
Directors
According to the 2025 annual accounts
Director · represented by Asselman Lode
Also active at: L4P Invest, WOLFMAN, AMOPHAR +1 more
since 2022
INPHAGRO Besloten Vennootschap
Director · represented by Mc Cullough Sean
Also active at: LIFE MEDICAL, LIFE MEDICAL SOLUTIONS, FIDELMED +5 more
since 2022
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Molenberglei 36
2627 Schelle
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
LIFE MEDICAL same network
€ 384,578 gross margin · 2025
INPHAGRO same network
€ 79,500 revenue · 2025
WOLFMAN same network
€ 126,568 gross margin · 2025
AMOPHAR same network
€ 83,196 gross margin · 2025
ALL-in-1 same network
€ 26.3 million revenue · 2025
+1 more
Details
- Company number
- 0795.483.142
- VAT number
- BE 0795.483.142
- Registered office
- Molenberglei 36, 2627 Schelle
- Names & denominations
- Amophar OTC · Amophar
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 December 2022
- Peppol
- Active · Active since 22 Oct 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen